Therapeutic EUS is a growing and exciting field that is advancing endoscopic treatments for patients with complex pancreaticobiliary diseases. This web page includes physician videos and case studies, and a step by step reference guide for the AXIOS™ Stent and Delivery System.*
Focus on New Technologies: Lecture Series
Dr. Binmoeller, founder of Xlumena and inventor of the AXIOS System, discusses the features and intended benefits of the AXIOS Stent and Delivery System.
Dr. Binmoeller talks about the future of interventional endoscopy and his passion for being inventive and innovative that led to the development of the AXIOS technology.
Video Case Studies
*The AXIOS™ Stent and Electrocautery-Enhanced Delivery System Indications for Use:
• US: The AXIOS Stent and Electrocautery-Enhanced Delivery System is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts 6cm in size, with >70% fluid content that are adherent to the gastric or bowel wall. Once place, the AXIOS Stent functions as an access port allowing passage of standard and therapeutic endoscopes to facilitate debridement, irrigation and cystoscopy. The stent is intended for implantation up to 60 days and should be removed upon confirmation of pseudocyst resolution.
• Europe: The Hot AXIOS Stent and Electrocautery Enhanced Delivery System is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of a pancreatic pseudocyst, walled-off necrosis (>70% fluid content) or the biliary tract.
ENDO-348205-AA October 2015